Ha, find me a medical device company that doesn't call their...

Ha, find me a medical device company that doesn't call their product the gold standard! I am not a medical expert so I won't comment on that. From my point of view, I see two companies with similar products who have been given the same opportunity into the US market, but one company has increased by 100%, the other by 5%. From memory the BP+ is significantly cheaper as well (more than half price I believe), but that can all change based on margins and sales contracts.

Like I said, I have only taken a small position. I have concerns as to why it took Uscom three weeks longer than Atcor to make the same announcement. Hopefully the management have a good answer.

Regardless, the huge revenue growth in the last quarterly came primarily from the 1A device, so anything the BP+ can do is blue sky.